NO952495D0 - Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister - Google Patents

Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister

Info

Publication number
NO952495D0
NO952495D0 NO952495A NO952495A NO952495D0 NO 952495 D0 NO952495 D0 NO 952495D0 NO 952495 A NO952495 A NO 952495A NO 952495 A NO952495 A NO 952495A NO 952495 D0 NO952495 D0 NO 952495D0
Authority
NO
Norway
Prior art keywords
diaryl
fused heterocyclic
leukotriene antagonists
heterocyclic acids
compounds
Prior art date
Application number
NO952495A
Other languages
English (en)
Other versions
NO313831B1 (no
NO952495L (no
Inventor
Robert N Young
Marc Labelle
Yves Leblanc
Yi Bin Xiang
Cheuk L Lau
Claude Dufresne
Yves Gareau
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of NO952495D0 publication Critical patent/NO952495D0/no
Publication of NO952495L publication Critical patent/NO952495L/no
Publication of NO313831B1 publication Critical patent/NO313831B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
NO19952495A 1992-12-22 1995-06-21 Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister NO313831B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99486992A 1992-12-22 1992-12-22
PCT/CA1993/000541 WO1994014815A1 (en) 1992-12-22 1993-12-15 Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists

Publications (3)

Publication Number Publication Date
NO952495D0 true NO952495D0 (no) 1995-06-21
NO952495L NO952495L (no) 1995-08-22
NO313831B1 NO313831B1 (no) 2002-12-09

Family

ID=25541163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19952495A NO313831B1 (no) 1992-12-22 1995-06-21 Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister

Country Status (23)

Country Link
EP (1) EP0604114B1 (no)
KR (1) KR100310552B1 (no)
CN (1) CN1040213C (no)
AT (1) ATE192448T1 (no)
AU (1) AU672837B2 (no)
CA (1) CA2111372C (no)
CZ (1) CZ290829B6 (no)
DE (1) DE69328540T2 (no)
DK (1) DK0604114T3 (no)
ES (1) ES2145765T3 (no)
FI (1) FI111368B (no)
GR (1) GR3033985T3 (no)
HU (1) HU222274B1 (no)
IL (1) IL108050A (no)
MX (1) MX9400022A (no)
NO (1) NO313831B1 (no)
NZ (1) NZ258835A (no)
PL (1) PL177967B1 (no)
PT (1) PT604114E (no)
RU (1) RU2154065C2 (no)
SK (1) SK282409B6 (no)
WO (1) WO1994014815A1 (no)
ZA (1) ZA939560B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472964A (en) * 1992-12-22 1995-12-05 Merck Frosst Canada, Inc. Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
US5350760A (en) * 1993-08-04 1994-09-27 Merck Frosst Canada, Inc. Aza-5,5-fused hetrocyclic acids as leukotriene antagonists
TW448160B (en) * 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
US5491077A (en) * 1994-07-20 1996-02-13 Merck & Co., Inc. Microbial method
US5427933A (en) * 1994-07-20 1995-06-27 Merck & Co., Inc. Reduction of phenylalkyl ketones to the corresponding (S)-hydroxy derivatives using mucor hiemalis IFO 5834
US5523477A (en) * 1995-01-23 1996-06-04 Merck & Co., Inc. Process for the preparation of 1-(thiomethyl)-cyclopropaneacetic acid
US5750539A (en) * 1995-06-07 1998-05-12 Merck Frosst Canada Heteroaryl diol acids as leukotriene antagonists
AU2003244427A1 (en) * 2002-02-06 2003-09-02 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
US7271268B1 (en) 2006-12-22 2007-09-18 Formosa Laboratories Inc. Process for preparation of [1-(mercaptomethyl)cyclopropyl]acetic acid and related derivatives
RU2449807C2 (ru) * 2009-11-16 2012-05-10 Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" Способ лечения эндотоксикоза при хроническом пиелонефрите

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957932A (en) * 1987-11-25 1990-09-18 Merck Frosst Canada, Inc. Benzoheterazoles
HUT61980A (en) * 1990-10-12 1993-03-29 Merck Frosst Canada Inc Process for producing saturated hydroxyalkylquinoline acids and pharmaceutical compositions comprising such compounds as active ingredient
ES2114882T3 (es) * 1990-10-12 1998-06-16 Merck Frosst Canada Inc Acidos hidroxialquilquinolinos insaturados como antagonistas de leucotrienos.
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
FI953104A0 (fi) 1995-06-21
CA2111372A1 (en) 1994-06-23
ZA939560B (en) 1994-08-11
PT604114E (pt) 2000-09-29
GR3033985T3 (en) 2000-11-30
PL309408A1 (en) 1995-10-02
EP0604114A1 (en) 1994-06-29
FI111368B (fi) 2003-07-15
HU9501842D0 (en) 1995-08-28
EP0604114B1 (en) 2000-05-03
CN1040213C (zh) 1998-10-14
NZ258835A (en) 1997-06-24
CZ290829B6 (cs) 2002-10-16
CZ165395A3 (en) 1996-01-17
HUT71810A (en) 1996-02-28
DE69328540D1 (de) 2000-06-08
IL108050A (en) 1998-06-15
SK282409B6 (sk) 2002-01-07
ES2145765T3 (es) 2000-07-16
PL177967B1 (pl) 2000-02-29
DK0604114T3 (da) 2000-08-07
CA2111372C (en) 2007-01-16
AU5257993A (en) 1994-07-07
FI953104A (fi) 1995-06-21
IL108050A0 (en) 1994-04-12
AU672837B2 (en) 1996-10-17
RU2154065C2 (ru) 2000-08-10
ATE192448T1 (de) 2000-05-15
RU95113598A (ru) 1997-06-10
SK82295A3 (en) 1995-12-06
KR100310552B1 (ko) 2001-12-17
NO313831B1 (no) 2002-12-09
HU222274B1 (hu) 2003-05-28
MX9400022A (es) 1995-01-31
CN1094051A (zh) 1994-10-26
DE69328540T2 (de) 2001-01-04
KR950704325A (ko) 1995-11-17
NO952495L (no) 1995-08-22
WO1994014815A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
DE69129257D1 (de) Ungesättigte Hydroxyalkylchinolinsäuren als Leukotrien-Antagonisten
MX9302033A (es) Acidos de hidroxialquilquinolina fluorados como antagonistas de leucotrieno.
NO920681D0 (no) Kinolinholdige ketosyrer som leukotrien-antagonister
NO952495L (no) Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister
MX9101556A (es) Acidos hidroxialquilquinolina eter como antagonistas de leucotrieno.